Cashed up & ready to go: Mesoblast forges funding deal with top shareholder
Inflammatory conditions medicine developer Mesoblast (ASX:MSB) is trading up more than 3%…
Mesoblast Limited (ASX:MSB)
About Mesoblast Limited
Key Information
MSB In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 21/11/2024 | Becoming a substantial holder | 1.87MB | 17K |
| 15/11/2024 | Results of Meeting | 251.44KB | 3.8K |
| 15/11/2024 | Final Director's Interest Notice | 265.82KB | 916 |
| 15/11/2024 | CEO Presentation to 2024 Annual General Meeting | 2.24MB | 56K |
| 15/11/2024 | Mesoblast Chair Message to 2024 AGM | 177.51KB | 2.1K |
| 14/11/2024 | Price Sensitive PS Response to ASX Price Query | 364.45KB | 23K |
| 12/11/2024 | Notification regarding unquoted securities - MSB | 17.57KB | 7.9K |
| 07/11/2024 | Warrant Prospectus Related to Convertible Note Agreement | 560.06KB | 6.2K |